<code id='1C7C325AA7'></code><style id='1C7C325AA7'></style>
    • <acronym id='1C7C325AA7'></acronym>
      <center id='1C7C325AA7'><center id='1C7C325AA7'><tfoot id='1C7C325AA7'></tfoot></center><abbr id='1C7C325AA7'><dir id='1C7C325AA7'><tfoot id='1C7C325AA7'></tfoot><noframes id='1C7C325AA7'>

    • <optgroup id='1C7C325AA7'><strike id='1C7C325AA7'><sup id='1C7C325AA7'></sup></strike><code id='1C7C325AA7'></code></optgroup>
        1. <b id='1C7C325AA7'><label id='1C7C325AA7'><select id='1C7C325AA7'><dt id='1C7C325AA7'><span id='1C7C325AA7'></span></dt></select></label></b><u id='1C7C325AA7'></u>
          <i id='1C7C325AA7'><strike id='1C7C325AA7'><tt id='1C7C325AA7'><pre id='1C7C325AA7'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:2
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Interest rates are at a 22
          Interest rates are at a 22

          1:10AshoppermakestheirwaythroughagrocerystoreonJuly12,2023inMiami,Florida.JoeRaedle/GettyImagesTheFe

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Biden announces an advanced cancer research initiative

          PresidentBidenspeaksintheEastRoomoftheWhiteHouseonTuesday.SusanWalsh/APWASHINGTON—PresidentBiden’sad